The course brings together a group of C2TN/IST scientists who, together with international experts, will present theoretical lectures on hot topics in radiopharmaceutical sciences, including radiolabelled chemistry, synthesis and conjugation of biomolecules, in silico approaches, methods for preclinical studies with cellular and animal models, and preclinical dosimetry. The theoretical lectures will be complemented by laboratory sessions to exemplify the various steps involved in the synthesis and evaluation of a potential radiopharmaceutical.
The course will also include a visit to the facilities of the Nuclear Medicine Service of the Fundação Champalimaud, a Portuguese foundation that focuses on advanced biomedical research to provide translational and interdisciplinary clinical care. Overall, trainees will acquire practical skills and scientific knowledge to understand the most important aspects required to bring radiopharmaceuticals from the bench to the patient's bedside.
The course is organised as part of the PRISMAP project, funded by the European Union's Horizon 2020 research and innovation programme, under grant agreement No 101008571 (PRISMAP).